secondari
metabolit
natur
sourc
made
signific
contribut
medicin
millennia
modern
medicin
drug
develop
natur
product
use
treat
infecti
diseas
cancer
hypertens
inflamm
research
immunomodul
applic
vaccin
sporad
stand
reason
field
could
better
exploit
biodivers
activ
compound
natur
sourc
new
chemic
entiti
nce
inspir
plant
microb
also
yield
signific
number
drug
increasingli
report
nce
deriv
fungi
marin
sourc
anim
although
immunopotenti
mine
plant
well
establish
organ
also
evalu
notabl
exampl
immunopotenti
plant
describ
follow
section
saponin
amphipath
glycosid
found
plant
marin
anim
bacteria
structur
one
hydrophil
glycosid
moieti
combin
lipophil
triterpen
deriv
saponin
attract
much
attent
due
rang
biolog
activ
includ
abil
stimul
immun
respons
make
prime
candid
adjuv
triterpenoid
saponin
quillaja
saponaria
studi
extens
due
strong
adjuv
potenti
quil
crude
extract
q
saponaria
bark
abil
produc
respons
activ
lymphocyt
respons
exogen
antigen
saponin
q
saponaria
includ
adjuv
sever
vaccin
formul
toxoplasma
gondii
human
immunodefici
viru
hiv
cytomegaloviru
also
use
alon
mixtur
aluminum
salt
liposom
amphipath
protein
lipid
form
immunestimul
complex
purifi
fraction
known
potent
adjuv
clinic
trial
quil
demonstr
hemolyt
effect
high
toxic
saponin
root
panax
ginseng
ginsenosid
thought
antiinflammatori
antitumor
adjuv
properti
hu
et
al
observ
increas
lymphocyt
prolifer
antibodi
respons
induc
staphlococcu
aureu
bacterin
dairi
cattl
mix
purifi
ginsenosid
rb
rivera
et
al
confirm
adjuv
activ
rb
determin
induc
balanc
immun
respons
balbc
mice
earlier
studi
show
ginseng
extract
administ
aluminum
hydroxid
adjuv
improv
antibodi
respons
viral
bacteri
antigen
favor
product
antibodi
wherea
addit
ginseng
induc
antibodi
suggest
ginseng
could
use
improv
potenc
aluminum
hydroxideeadjuv
vaccin
particularli
respons
desir
yesilada
et
al
determin
saponin
root
astragalu
membranaceu
induc
interleukin
il
activ
vitro
shown
power
immunostimulatori
activ
extract
also
abl
enhanc
specif
antibodi
product
cellular
respons
ovalbumin
mice
result
similar
produc
use
alum
quil
plant
yield
immunostimul
saponin
includ
panax
notoginseng
platycodon
grandiflorum
polygala
tomatin
glycoalkaloid
deriv
leav
unrip
fruit
wild
tomato
speci
lycopersicon
pimpinellifolium
thought
similar
charact
saponin
wide
recogn
strong
immunostimul
shown
well
toler
safe
mice
induc
hemolyt
activ
tissu
damag
granuloma
format
site
inocul
howev
induc
recruit
mononuclear
cell
within
h
immun
heal
et
al
administ
tomatin
alongsid
plasmodium
berghei
circumsporozoit
cs
peptid
balbc
mice
found
splenocyt
vaccin
mice
significantli
upregul
interferon
ifn
g
compar
control
addit
morrow
et
al
show
potenti
tomatin
adjuv
vaccin
protect
malaria
francisella
tularensi
establish
plant
polysaccharid
adjuv
inulin
deriv
root
asteracea
composita
famili
elicit
potent
humor
cellular
immun
respons
gamma
inulin
gi
use
contracept
influenza
hepat
b
malaria
vaccin
littl
side
effect
delta
inulin
potent
gi
greater
temperatur
stabil
advax
adjuv
produc
micro
particl
delta
inulin
formul
recombin
inactiv
vaccin
antigen
sever
preclin
studi
use
advax
evalu
broad
rang
pathogen
influenza
viru
sever
acut
respiratori
syndrom
hiv
listeria
hepat
b
advax
coadminist
vaccin
induc
ifng
iga
respons
detail
inulin
given
elsewher
book
polysaccharid
studi
immunestimul
properti
includ
base
mannos
interact
mannos
receptor
found
dendrit
cell
dc
combin
nanoparticl
mucos
vaccin
seem
grow
trend
varieti
plant
polysaccharid
mani
kind
fungi
includ
mushroom
endophyt
fungi
produc
metabolit
immunomodulatori
potenti
approxim
differ
speci
mushroom
thought
exist
studi
pharmacolog
properti
primari
metabolit
deriv
mushroom
consist
highmolecularweight
compound
polysaccharid
protein
polysaccharideeprotein
complex
pigment
secondari
metabolit
consist
triterpenoid
organ
acid
relat
compound
benzofuran
flavonoid
coumarin
alkaloid
tabl
summar
exampl
activ
compound
immunomodulatori
activ
medicin
mushroom
produc
highmolecularweight
bglucan
fig
stimul
innat
immun
cell
via
bind
pattern
recognit
receptor
found
macrophag
dc
watersolubl
highmolecularweight
bglucan
thought
better
immunopotenti
activ
also
acid
resist
ideal
oral
administr
thought
via
mucos
rout
interact
macrophag
receptor
intestin
wall
stimul
cytokin
attract
phagocyt
leukocyt
smiderl
et
al
report
bdglucan
agaricu
bisporu
agaricu
brasiliensi
stimul
proinflammatori
tumor
necrosi
factor
tnf
cyclooxygenas
cox
gene
express
concentr
mgml
respect
follow
incub
human
monocyt
cell
h
cordycep
cicada
parasit
fungu
grow
larva
insect
cicada
flammata
sinc
speci
mushroom
grow
insect
bodi
fruit
bodi
insect
bodi
extract
separ
methanol
extract
c
cicada
fruit
bodi
found
enhanc
human
mononuclear
cell
prolifer
stimul
phytohemagglutinin
cytokin
product
ifng
acid
polysaccharid
extract
myceli
cultur
fungu
cordycep
sinensi
also
shown
signific
product
proand
antiinflammatori
cytokin
induct
tnfa
il
mushroom
speci
intracellular
extracellular
polysaccharid
extract
ganoderma
neojaponicum
imazeki
enhanc
prolifer
increas
phagocytosi
toxic
observ
spragueedawley
rat
kozarski
et
al
report
extract
spore
ganoderma
lucidum
increas
ifng
stimul
human
peripher
blood
mononuclear
cell
h
endophyt
fungi
inhabit
plant
tissu
without
destroy
produc
substanc
caus
infect
host
cell
coevolut
mean
endophyt
produc
similar
compound
origin
plant
immunestimul
compound
includ
phomoxanthon
fig
isol
ethyl
acet
extract
endophyt
phomopsi
longicolla
phomoxanthon
significantli
increas
quantiti
hypodiploid
nuclei
human
b
lymphocyt
jurkat
lymphocyt
activ
murin
lymphocyt
natur
killer
nk
cell
macrophag
addit
endophyt
fungal
fraction
root
ocimum
sanctum
linn
reveal
glucosid
flavonoid
tannin
increas
phagocyt
activ
human
neutrophil
marin
spong
agalc
agalactosylceramid
agalc
agalactosyl
sphingolipid
compos
alink
sugar
lipid
moieti
fig
isol
extract
marin
okinawa
spong
call
agela
mauritaniu
glycolipid
present
receptor
antigenpres
cell
eg
dc
invari
receptor
natur
killer
nkt
cell
nkt
inkt
activ
rapidli
produc
larg
amount
immunomodulatori
cytokin
ifng
respect
cytokin
induct
lead
activ
varieti
innat
adapt
immun
cell
immunomodulatori
effect
agalc
molecul
vari
chemic
modif
sugar
fatti
acyl
chain
well
shorten
lipid
chain
natur
adjuv
immunopotenti
length
vaccin
formul
contain
natur
galcer
synthet
deriv
differ
antigen
found
protect
viral
infect
tumor
anim
model
tengval
et
al
demonstr
intranas
immun
herp
viru
type
glycoprotein
gd
agalc
confer
complet
protect
lethal
vagin
herp
simplex
challeng
mice
far
clinic
evalu
antitumor
activ
agalc
synthet
deriv
krn
demonstr
treatment
well
toler
induc
clinic
benefici
immun
respons
patient
chitosan
linear
polysaccharid
compos
b
link
dglucosamin
nacetyldglucosamin
fig
produc
treat
shrimp
crustacean
shell
sodium
hydroxid
wide
rang
polym
avail
term
molecular
weight
degre
deacetyl
chemic
modif
make
flexibl
materi
variat
applic
use
exampl
deliveri
system
adjuv
chitosan
broad
number
properti
includ
low
manufactur
cost
biocompat
low
level
intoler
appropri
antibodi
respons
mainli
addit
excel
mucoadhes
properti
make
suitabl
vaccin
administ
via
mucos
rout
abl
open
tight
junction
enabl
transport
antigen
immun
effector
site
sporad
report
use
nonvertebr
immunostimul
bee
produc
rang
complex
materi
biolog
activ
propoli
divers
term
chemic
constitu
bioactiv
bee
collect
resin
compound
differ
plant
part
bark
bud
flower
believ
relev
surviv
hive
materi
partial
digest
form
propoli
mani
use
beehiv
includ
hive
repar
protect
insect
weather
chang
well
microbi
infect
speci
bee
propoli
sampl
screen
chemic
content
biolog
effect
bee
pharmaci
believ
possess
bioactiv
compound
depend
locat
bee
flora
perimet
flight
path
hive
exist
local
prevail
diseas
tabl
fig
show
rang
immunomodulatori
compound
although
debat
rage
whether
antior
proinflammatori
earli
report
immunomodulatori
action
propoli
began
late
sinc
sever
studi
shown
promis
result
propoli
safe
effect
adjuv
mechan
action
yet
elucid
date
effect
attribut
enhanc
leukocyt
phagocyt
lymphocyt
activ
well
increas
immun
period
vaccin
induct
earli
immun
addit
mani
compound
show
immunostimulatori
activ
water
solubl
use
lipid
vesicl
liposom
increas
bioavail
flavonoidrich
liposom
enhanc
antigenspecif
igg
antibodi
induc
ifng
compar
propoli
alon
vivo
studi
orsatti
et
al
reveal
propoli
activ
initi
step
immun
respons
upregul
tolllik
receptor
product
proinflammatori
il
cytokin
mice
therebi
modul
mechan
innat
immun
mani
studi
assess
adjuv
potenti
propoli
employ
vitro
vivo
experi
result
often
contrari
orsi
examin
propoli
activ
macrophag
vitro
assay
measur
hydrogen
peroxid
nitric
oxid
level
indic
murin
periton
macrophag
activ
proinflammatori
effect
although
vitro
result
show
activ
signific
contrast
vivo
data
show
signific
elev
macrophag
activ
dosedepend
manner
coadministr
ifng
overal
data
show
nonspecif
proinflammatori
effect
propoli
aforement
studi
demonstr
capabl
propoli
extract
boost
immun
respons
indic
potenti
vaccin
use
studi
begun
investig
applic
encourag
find
methanol
extract
green
propoli
evalu
adjuv
potenti
swine
herp
viru
vaccin
result
show
signific
increas
antibodi
level
well
increas
cellular
immun
respons
evidenc
increas
express
ifng
messeng
rna
mrna
also
observ
propoli
extract
rais
percentag
anim
protect
lethal
dose
similarli
ethanol
extract
green
propoli
administr
oil
bovin
herp
viru
type
vaccin
result
signific
increas
antibodi
product
compar
anim
receiv
vaccin
alon
adjuv
effect
attribut
high
amount
artepillin
c
cinnam
acid
deriv
well
flavonoid
furthermor
colleagu
compar
effect
propoli
tradit
vaccin
adjuv
oil
emuls
aluminum
salt
porcin
parvoviru
vaccin
three
adjuv
strongli
activ
enhanc
antibodi
titer
well
lymphocyt
level
propoli
superior
two
adjuv
term
produc
earlier
induct
antibodi
product
propoli
along
plant
extract
pollen
andor
alo
polysaccharid
combin
inactiv
bordetella
avium
vaccin
administ
chicken
combin
produc
signific
increas
antibodi
titer
cytokin
lymphocyt
blood
count
compar
vaccin
alon
chu
test
water
extract
propoli
adjuv
aeromona
hydrophila
formalin
kill
antigen
immun
carp
carassiu
auratu
gibelio
intraperiton
administr
result
show
increas
surviv
rate
propoli
vaccin
group
compar
group
receiv
vaccin
alon
bee
venom
bv
essenti
complex
mixtur
compos
peptid
toxic
protein
bioactiv
compon
main
compon
acid
hemolyt
peptid
call
melittin
constitut
venom
dri
weight
respons
observ
effect
bv
number
studi
report
melittin
neutral
effect
lipopolysaccharid
lp
differ
murin
macrophag
cell
line
inhibit
nuclear
factorkb
bind
dna
phosphoryl
inhibitor
kappa
b
ikb
express
proinflammatori
cytokin
tnfa
inhibit
ino
product
express
express
prostaglandin
e
howev
antiinflammatori
effect
corrobor
stuhlmeier
report
signific
increas
mrna
level
sever
proinflammatori
gene
includ
tnfa
furthermor
protein
elev
fibroblastlik
synoviocyt
dermal
fibroblast
mononuclear
cell
follow
exposur
bv
melittin
studi
also
shown
bv
influenc
cell
cytokin
rather
dose
time
also
shown
impact
whether
bv
immunostimulatori
immunosuppress
one
studi
evalu
adjuv
potenti
melittin
intranas
vaccin
tetanu
diphtheria
toxoid
antigen
found
antibodi
titer
depend
dose
melittin
coadminist
recent
studi
confirm
bv
compon
act
synergist
lp
promot
cytokin
releas
given
limit
studi
carri
evalu
bv
compon
vaccin
work
requir
futur
look
promis
major
hurdl
natur
product
research
low
yield
activ
compon
interest
subsequ
amount
need
research
develop
well
ultim
clinic
use
therefor
improv
extract
isol
highthroughput
screen
techniqu
requir
current
develop
one
approach
use
drug
deliveri
strategi
directli
target
appropri
immun
cell
controlledreleas
manner
way
reduc
drug
need
overcom
low
bioavail
particularli
lipophil
compound
howev
use
synthet
equival
probabl
feasibl
way
ensur
quantiti
qualiti
control
also
allow
pharmaceut
compani
modifi
patent
nce
howev
although
may
possibl
small
molecul
alway
possibl
complex
entiti
polysaccharid
challeng
result
decad
research
time
initi
compound
elucid
commerci
develop
exampl
took
around
year
first
discov
activ
taxu
brevifolia
extract
develop
paclitaxel
formul
clinic
trial
purif
activ
substanc
take
vari
amount
time
depend
presenc
relat
compound
may
interfer
posit
neg
separ
identif
process
es
normal
appropri
nuclear
magnet
reson
analysi
extract
would
carri
determin
natur
main
substanc
mixtur
follow
select
chromatograph
method
enabl
separ
fraction
method
may
especi
applic
small
druglik
molecul
larger
molecular
weight
substanc
polysaccharid
challeng
howev
may
elucid
xray
crystallographi
good
crystal
obtain
prepar
crude
extract
plant
sourc
often
yield
surpris
result
highlight
need
robust
qualiti
assur
method
use
crude
natur
product
extract
fraction
medicin
adjuv
mani
extract
plant
use
tradit
indigen
peopl
around
globe
often
prepar
use
either
water
form
dilut
aqueou
ethanol
extract
yield
decoct
tinctur
exampl
artemisia
annua
aqueou
extract
use
local
malawi
treat
patient
infect
malaria
main
activ
ingredi
well
known
lipidsolubl
sesquiterpenoid
artemisinin
pure
form
insolubl
water
came
real
surpris
chemist
involv
work
detect
amount
artemisinin
aqueou
extract
annua
plant
sampl
also
therapeut
relev
amount
artemisinin
lutz
heid
person
commun
aig
rel
larg
proport
activ
ingredi
undoubtedli
due
presenc
surfactanttyp
compon
plant
materi
act
natur
solubil
agent
waterinsolubl
artemisinin
differ
natur
product
sourc
may
also
present
challeng
exampl
case
mushroom
six
crucial
concept
need
address
cultiv
difficult
collect
time
procedur
season
environ
impact
quantiti
bioactiv
compoundsdthi
also
appli
plant
cultiv
method
requir
good
manufactur
practic
growth
mushroom
slow
bioactiv
compound
low
concentr
isol
identif
test
bioactiv
compound
need
studi
understand
immunomodulatori
mechan
action
proper
use
qualiti
efficaci
product
need
guarante
submerg
cultiv
use
bioreactor
one
method
use
increas
cultur
mushroom
product
compound
tabl
show
variou
compani
produc
mushroom
product
clinic
applic
greatest
problem
area
research
lack
standard
limit
clinic
trial
carri
system
biolog
approach
use
assess
vaccin
effect
difficulti
look
gene
express
immun
cell
sinc
mani
cell
type
involv
immun
respons
blood
sampl
provid
inform
mani
lineag
differenti
state
cell
involv
immun
respons
character
gene
signatur
rang
vaccin
result
design
gene
chip
highthroughput
analysi
gene
express
respons
vaccin
natur
adjuv
immunopotenti
vaccin
plu
adjuv
system
biolog
approach
vaccin
optim
also
use
omic
technolog
proteom
metabolom
sever
system
use
assess
effect
adjuv
improv
immun
respons
antigen
anim
model
wide
use
frequent
debat
anim
model
translat
action
human
whole
fresh
blood
antigen
plu
adjuv
follow
monitor
tnfa
ifng
releas
enzymelink
immunosorb
assay
elisa
assay
use
develop
vaccin
associ
adjuv
includ
stimul
lymphocyt
prolifer
cytokin
productiondeith
ifng
tnfa
quantit
express
cell
activ
marker
cell
surfac
use
fluorescenceactiv
cell
sorter
fac
quantit
differ
lymphocyt
subpopul
fac
eg
augment
nk
cell
cytotox
stimul
tnfa
product
macrophag
respons
lp
stimul
antibodi
plaqueeform
cell
antibodi
product
vivoeassoci
assay
includ
stimul
antibodi
titer
specif
antigen
determin
cytokin
profil
gradual
move
toward
systemsbas
approach
assess
vaccin
efficaci
applic
omic
technolog
also
includ
wide
use
technolog
date
applic
microarray
technolog
examin
rna
express
posttreat
addit
microchip
technolog
appli
wellestablish
assay
elisa
enzymelink
immunospot
assay
applic
microarray
technolog
recent
review
anoth
commonli
appli
assay
use
luminex
technolog
case
bead
bear
either
singl
dna
strand
antibodi
introduc
sampl
format
analyt
interest
captur
technolog
highli
suitabl
quantifi
respons
antigen
via
measur
array
cytokin
allow
system
biolog
approach
use
assess
vaccin
respons
omic
ladder
applic
proteom
adjuv
research
appear
widespread
howev
use
metabolom
find
lowmolecularweight
metabolit
marker
vaccin
effect
begin
emerg
metabolom
simpli
aim
profil
metabolit
within
biolog
fluid
tissu
effect
mean
somewher
sever
thousand
metabolit
monitor
depend
instrument
technolog
use
screen
mine
natur
resourc
effect
safe
adjuv
appear
daunt
prospect
nevertheless
need
better
gener
adjuv
mean
still
valuabl
approach
understand
immun
system
grow
improv
technolog
advanc
term
screen
manufactur
appli
effect
area
research
worth
monitor
